Announcing the New Journal of Law and the Biosciences
The Petrie-Flom Center and Harvard Law School are delighted to announce our partnership with Duke University, Stanford University, and Oxford University Press to launch a new peer-reviewed, open access, online journal in 2014: Journal of Law and the Biosciences (JLB).
JLB will become the preeminent outlet to publish cutting-edge scholarship wherever law and the biosciences intersect. The journal will take a broad and interdisciplinary view of these areas, publishing articles on topics generally considered part of bioethics or neuroethics, such as the ethical, legal, and social implications of reproductive technologies, genetics, stem cell research, neuroscience, or human biological enhancement. At the same time, JLB will be a home for work that speaks directly to legal issues where the biosciences can be involved, such as food and drug regulation, biosciences patent law, scientific evidence, and criminal responsibility.
Rhodri Jackson, Senior Publisher, Law Journals and Oxford Open, OUP said: “OUP has a very strong presence in intellectual property and patent law, and in pure bioscience publishing. We’re very excited by the opportunity Journal of Law and the Biosciences presents to unite both of these strengths, and tap into a booming area of research. We couldn’t have picked better partners than Duke, Harvard, and Stanford, and look forward to working with the editors. Furthermore, JLB’s OA nature reflects our on-going drive to explore open access publishing opportunities in the law.”
JLB’s founding co-editors in chief are I. Glenn Cohen from Harvard, Nita Farahany from Duke, and Hank Greely from Stanford. Greely, speaking for the editors-in-chief, said “We are thrilled to be launching this journal. Law and the biosciences is an emerging field of great social importance; having a dedicated, peer-reviewed journal will advance our understanding of crucial issues, while helping to build the field. OUP is a wonderful partner for this effort.” JLB will also be assisted by an editorial board. The current board is composed of nearly thirty leading scholars working in the area, from law, bioethics, philosophy, neuroscience, psychology, and other disciplines.
Currently, submissions to JLB should be sent to Melissa Segal, Managing Editor. However, within the next couple of weeks, submissions will be handled through Scholar One, an on-line submission and peer review tool. The three issues in JLB’s first volume will be published in March, July, and November, 2014. Given the nature of on-line publication, some articles will be posted in advance of their slated issue.bioethics biotechnology enhancement genetics health law policy neuroscience reproductive technologies stem cells